Drugs / JK500 cell injection
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05519384 | Sep 2022 → Nov 2023 | childhood acute myeloid leukemia | Institute of Hematology & Blood Diseases Hospital, China | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JK500 cell injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05519384 ↗ |
| Modality | Cell therapy | “regenerative natural killer (NK) cells derived from human embryonic stem cells” NCT05519384 ↗ |